Biotech | August 11, 2021
Moderna to set up mRNA manufacturing in Canada
The collaboration will support Canada with direct access to rapid pandemic response capabilities
The collaboration will support Canada with direct access to rapid pandemic response capabilities
Company working on COVID vaccine INO 4800
Advances deployment of mRNA technology across vaccines and therapeutics development
In the agreement, Marcor, an Azelis Americas company, will distribute the SPI Pharma product lines in the United States, and Azelis Canada Pharma Division will be responsible for the Canadian marketplace
He will be responsible for the company's overall strategy and provide the necessary direction and dynamic leadership to R&D, manufacturing, business development, and commercial operations
CDSCO to fast-track trials and approval for COVID19 vaccine
He will be stationed at the company HQ in Bengaluru, India
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
WHO prequalification enables the procurement of ROTAVAC 5D by UN agencies namely UNICEF and PAHO
Subscribe To Our Newsletter & Stay Updated
